Skip to content
Screener

Tandem Diabetes Care TNDM Accrued Expenses

Accrued Expenses at other companies

Insulet logo
InsuletPODD
$602M
Medtronic logo
MedtronicMDT
$3.63B-1.3%
Beta Bionics logo
Beta BionicsBBNX
$17.19M+28.3%
Embecta Corp. logo
Embecta Corp.EMBC
$41.4M-8.0%
AdaptHealth logo
AdaptHealthAHCO
$3.89M-87.3%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$7.51M-1.2%

Other financials

Income statement

See full
Revenue$254.6M+5.8%
Gross profit$144.8M+15.0%
Operating income-$13.8M+73.4%
Net income-$21.2M+59.6%
EPS (diluted)-$0.31+60.3%

Balance sheet

See full
Cash & equivalents$62.8M-2.0%
Total debt$739.3M+64.6%
Total equity$130.4M-2.2%
Total assets$1.2B+31.8%

Cash flow

See full
Operating cash flow-$34.6M-265%
CapEx$4.1M-34.7%
Free cash flow-$38.7M-146%

Valuation

See full
Market cap$1.59B+132%
Enterprise value$2.26B+112%
P/S1.5×+0.8×

Profitability

See full
Gross margin56%+3.5pp
Operating margin-4.4%-1.9pp
Net margin-6.1%-2.5pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-48%-17.5pp
Debt / equity5.7×+2.3×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001438133-26-000125
AssetsJune 30, 2026 / (Unaudited)December 31, 2025 / (Note 1)
Current liabilities:
Accounts payable$64,130$47,067
Accrued expenses25,53921,012
Employee-related liabilities53,26170,409
Operating lease liabilities20,26519,472
Deferred revenue8,4309,527
Other current liabilities81,38075,237
Total current liabilities253,005242,724

Item 1. Financial Statements.

FAQ

What is Tandem Diabetes Care's accrued expenses?
Tandem Diabetes Care (TNDM) reported accrued expenses of $53.26M in Q2 2026.
How has Tandem Diabetes Care's accrued expenses changed year-over-year?
Tandem Diabetes Care's accrued expenses increased by 3.0% year-over-year, from $51.69M to $53.26M.
What is the long-term trend for Tandem Diabetes Care's accrued expenses?
Over 5 years (2020 to 2025), Tandem Diabetes Care's accrued expenses has grown at a 15.6% compound annual growth rate (CAGR), from $34.16M to $70.41M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Tandem Diabetes Care's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude